Sanai Health Industry Group Company Limited (HK:1889) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Sanai Health Industry Group Company Limited has issued a profit warning, anticipating a significant 40% drop in revenue and a decrease in net profit to approximately RMB10.0 million for the first half of 2024, compared to RMB15.5 million in the same period of 2023. The decline is attributed to lower pharmaceutical sales volume, increased costs for traditional Chinese herbal materials, the absence of high-margin finance leasing interest income, and heightened legal and professional expenses due to corporate actions, despite some offset from gains on subsidiary disposals. The company urges shareholders and potential investors to exercise caution when dealing with its shares.
For further insights into HK:1889 stock, check out TipRanks’ Stock Analysis page.
